We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The UK Government is consulting on proposed legislative amendments to widen access to take-home supplies of naloxone, without a prescription.
First published during the 2022 to 2024 Sunak Conservative government
Introduction The Department of Health and Social Care (DHSC), the…
This consultation collected views on expanding the use of naloxone. It ran for 8 weeks and was open to all interested individuals and organisations.
First published during the 2019 to 2022 Johnson Conservative government
Introduction to naloxone Naloxone is a drug that reverses the effects of…
The Advisory Council on the Misuse of Drugs (ACMD) seeks to gather insight into current government-led drug prevention policies and landscape across the UK.
ACMD Advisory Council on the Misuse of Drugs ACMD Chair: Professor Owen…
The Advisory Council on the Misuse of Drugs call for evidence, collecting written evidence to better understand internet-facilitated drug markets (IFDMs).
The ACMD will use your response to help them formulate advice to government about drug use in ethnic minority groups.
We are seeking views to enable us to determine legitimate uses of nitrous oxide.
A 10-year plan to cut crime and save lives by reducing the supply and demand for drugs and delivering a high-quality treatment and recovery system.
An independent review into the use and supply of illicit drugs, seeking views on how to reduce harm to individuals and society.
The government's response to the Advisory Council on the Misuse of Drugs (ACMD) report 'Ageing cohort of drug users'.
Consultation about changes to the national drug treatment monitoring system (NDTMS) annual reports format and the methodology for the young people's report.
Government response to recommendations from the Advisory Council on the Misuse of Drugs.
The government's response to the Health and Social Care Committee's report.
We're inviting feedback on proposed changes to the criminal justice intervention teams dataset collected for the national drug treatment monitoring system.
Terms of reference of the expert reference group advising the review of prescribed medicines.
The drug strategy 2017 sets out how the government and its partners, at local, national and international levels, will take new action to tackle drug misuse and the harms it causes.
First published during the 2016 to 2019 May Conservative government
ACMD chair Les Iversen writes to Sarah Newton, Minister for Vulnerability, Safeguarding and Countering Extremism, about phytocannabinoids.
ACMD’s report on diversion and illicit supply of medicines.
A call for evidence to inform an independent review into the effects on employment outcomes of drug or alcohol addiction and obesity.
The second and concluding report on opioid substitution therapy from the Advisory Council on the Misuse of Drugs (ACMD).
Public Health England is undertaking a review on behalf of the departments of health in England, Scotland, Wales and Northern Ireland.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).